CNTN

MKT CAP:$119M

Canton Strategic Holdings Inc

Market Cap

$119M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.56+$0.18 (+5.33%)

Apr 22, 2026

Company Details

Canton Strategic Holdings, Inc. focuses on leveraging Canton Coin and supporting the Canton network to advance institutional blockchain adoption and the digitization of financial markets. The company also involved in research and developmen...

CEO

Mark Wendland

IPO Date

Mar 28, 2024

Website

www.cantonstrategic.com

Key Metrics TTM

Revenue

$0

— YoY

Net Income

-$36M

EPS (Diluted)

-$1.12

Free Cash Flow

-$16M

Revenue / Share

$0.00

Gross Margin

—

Operating Margin

—

Net Margin

—

FCF Margin

—

P/S

—

P/E

—

Earnings Reports

FY 2025

Mar 31, 2026

$0EPS -$1.12

Q4 2025

Mar 31, 2026

$0EPS $0.85

Q3 2025

Nov 12, 2025

$0EPS -$0.34

Q2 2025

Aug 14, 2025

$0EPS -$0.64

Q1 2025

May 12, 2025

$0EPS -$0.99

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 22	$0	$0	-$1M
Q2 22	$0	$0	-$2M
Q3 22	$0	$0	-$2M
Q4 22	$0	$0	-$2M
Q1 23	$0	$0	-$3M
Q2 23	$0	$0	-$2M
Q3 23	$0	$0	-$2M
Q4 23	$0	$0	-$3M
Q1 24	$0	$0	-$2M
Q2 24	$0	$0	-$2M
Q3 24	$0	$0	-$4M
Q4 24	$0	$0	-$4M
Q1 25	$0	$0	-$3M
Q2 25	$0	$0	-$2M
Q3 25	$0	$0	-$2M
Q4 25	$0	$0	-$14M

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 22	-$3M	-$3M
Q2 22	-$2M	-$2M
Q3 22	-$2M	-$2M
Q4 22	-$1M	-$1M
Q1 23	-$3M	-$3M
Q2 23	-$2M	-$2M
Q3 23	-$909.0K	-$909.0K
Q4 23	-$1M	-$1M
Q1 24	-$3M	-$3M
Q2 24	-$2M	-$2M
Q3 24	-$3M	-$3M
Q4 24	-$3M	-$3M
Q1 25	-$3M	-$3M
Q2 25	-$1M	-$1M
Q3 25	-$2M	-$2M
Q4 25	-$10M	-$10M

Capital Expenditures

Quarter	CapEx
Q1 22	$0
Q2 22	$1
Q3 22	$0
Q4 22	$0
Q1 23	$0
Q2 23	$3
Q3 23	$0
Q4 23	$0
Q1 24	$1
Q2 24	$3
Q3 24	$3
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 22	—	-7.9%
Q2 22	—	+49.1%
Q3 22	—	+293.2%
Q4 22	—	+1138.8%
Q1 23	—	+100.9%
Q2 23	—	+44.5%
Q3 23	—	-13.3%
Q4 23	—	+43.3%
Q1 24	—	-13.5%
Q2 24	—	+0.4%
Q3 24	—	+109.5%
Q4 24	—	+52.0%
Q1 25	—	+8.5%
Q2 25	—	-22.0%
Q3 25	—	-45.8%
Q4 25	—	+253.9%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 22	$19.4K	—
Q2 22	$338.6K	—
Q3 22	$240.8K	—
Q4 22	$202.0K	—
Q1 23	$345.4K	—
Q2 23	$158.0K	—
Q3 23	$158.0K	—
Q4 23	$170.4K	—
Q1 24	$153.6K	—
Q2 24	$153.6K	—
Q3 24	$191.9K	—
Q4 24	$211.1K	—
Q1 25	$219.2K	—
Q2 25	$559.4K	—
Q3 25	$527.0K	—
Q4 25	$2M	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 22	$307.8K	—	$1M
Q2 22	$455.5K	—	$1M
Q3 22	$831.8K	—	$1M
Q4 22	$683.2K	—	$1M
Q1 23	$1M	$2M	—
Q2 23	$1M	$1M	—
Q3 23	$488.2K	—	$1M
Q4 23	$992.7K	$2M	—
Q1 24	$1M	—	$1M
Q2 24	$999.6K	—	$1M
Q3 24	$2M	$2M	—
Q4 24	$2M	$2M	—
Q1 25	$594.1K	—	$2M
Q2 25	$546.2K	$1M	—
Q3 25	$277.8K	—	$2M
Q4 25	$2M	$12M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$11M	$0	$11M
Q2 22	$9M	$0	$9M
Q3 22	$8M	$0	$8M
Q4 22	$7M	$0	$7M
Q1 23	$4M	$0	$4M
Q2 23	$4M	$0	$4M
Q3 23	$3M	$0	$3M
Q4 23	$11M	$0	$11M
Q1 24	$8M	$0	$8M
Q2 24	$8M	$0	$8M
Q3 24	$5M	$0	$5M
Q4 24	$4M	$0	$4M
Q1 25	$1M	$0	$1M
Q2 25	$2M	$0	$2M
Q3 25	$8M	$0	$8M
Q4 25	$17M	$0	$17M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 22	28K	-7.0%	-5.9%
Q2 22	31K	+9.4%	+12.4%
Q3 22	31K	-0.4%	+12.0%
Q4 22	31K	-0.2%	+1.3%
Q1 23	31K	0.0%	+8.9%
Q2 23	40K	+29.8%	+29.2%
Q3 23	46K	+15.7%	+50.0%
Q4 23	783K	+1597.1%	+2449.0%
Q1 24	784K	+0.2%	+2452.9%
Q2 24	962K	+22.7%	+2313.4%
Q3 24	2M	+60.8%	+3255.2%
Q4 24	2M	+27.6%	+152.2%
Q1 25	3M	+30.3%	+228.2%
Q2 25	3M	+11.8%	+199.1%
Q3 25	6M	+116.9%	+303.4%
Q4 25	32M	+413.5%	+1523.8%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 22	—	—
Q2 22	—	—
Q3 22	—	—
Q4 22	—	—
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	$0	2
Q1 25	$0	2
Q2 25	$0	2
Q3 25	$0	2
Q4 25	$0	12

Revenue / Employee